Germ Exposure and Common Sense

I had a great craft fair on Saturday. I had a table at a busy craft fair and had some great sales. Between sales I chatted with the women in the booth next to me. Both our booths were set up so that we squeezed behind them on the same side. They had several friends stop by and chat with them for a bit.One woman pushed right up front to talk to them behind their booth, with her cold and told them loudly that she had a bad cold and then about one of her chemo patients who had also stopped by the booth earlier in the day. She sneezed a couple of times while there as well.I was appalled that she was out at a craft show with her cold. She had shoved into the booth with her germs and sneezed on people. And she was a chemo nurse and treated patients while sick.And she sneezed on me. With my compromised immune system.I know, I know that I am the one with the compromised immune system that is way more susceptible to germs than the average person. I know that I am also the one who goes out in public and increases my risk of being exposed to germs. But I do expect that most people will have the common courtesy and common sense of staying home when they have a cold.I used to work with a guy who would come to work when he was sick. And he didn't seem to care if he shared his germs. I finally complained about him because if I got a cold I would be sick for two weeks.Yesterday I was supposed to go to a friend's funeral but I woke up feeling like I was coming down with a cold. That meant for...
Source: Caroline's Breast Cancer Blog - Category: Cancer & Oncology Tags: aggravation germs immune system Source Type: blogs

Related Links:

Conclusion: it was difficult to experience and accept changes in work activities. The support of family, friends and coworkers was paramount to cope with this process, which should also be taken into account by the health team, especially nursing.RESUMO Objetivo: compreender o significado das atividades de trabalho para mulheres jovens com c âncer de mama. Método: estudo qualitativo que utilizou como referencial teórico o Interacionismo Simbólico e, metodológico, o Discurso do Sujeito Coletivo. Desenvolvido em um ambulatório de mastologia e em um núcleo de reabilitaç&a...
Source: Texto e Contexto - Enfermagem - Category: International Medicine & Public Health Source Type: research
Might the Breast Cancer Index effectively predict benefit from extended endocrine treatment? Data from the aTTom trial provides insight.Annals of Oncology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
Undergoing earlier menopause is a sign of a greater burden of age-related damage and dysfunction, so it should not be surprising to see that this correlates with a greater incidence of chronic disease in the years thereafter. People with a greater burden of cell and tissue damage tend to exhibit all of the manifestations of aging earlier than their less damaged peers. These variations in damage burden and consequences from individual to individual are near all the results of lifestyle choices, particularly smoking, weight, and exercise, and environmental factors such as exposure to chronic viral infection. Genetics plays o...
Source: Fight Aging! - Category: Research Authors: Tags: Daily News Source Type: blogs
      ·Application is being reviewed under FDA ’s Real-Time Oncology Review pilot programmeBasel, 27 January 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced the completion of a supplemental Biologics License Application (sBLA) submission to the US Food and Drug Administration (FDA) for Tecentriq® (atezolizumab) in combination with Avastin® (bevacizumab), for the treatment of people with unresectab le hepatocellular carcinoma (HCC) who have not received prior systemic therapy. The FDA is reviewing the application under the Real-Time Oncology Review pilot programme, wh...
Source: Roche Investor Update - Category: Pharmaceuticals Source Type: news
.
Source: Neuro-Ophthalmology - Category: Opthalmology Authors: Source Type: research
ConclusionThis is the first study to reveal that the interaction of GR and AR did influence the clinical outcome of TNBC patients and GCs induced cell migration in TNBC cells.
Source: Breast Cancer Research and Treatment - Category: Cancer & Oncology Source Type: research
This study aimed to validate whether the recently-proposed prognostic grading system, initial brain metastasis velocity (iBMV), is applicable to breast cancer patients receiving stereotactic radiosurgery (SRS). We focused particularly on whether this grading system is useful for patients with all molecular types, i.e., positive versus negative for EsR, PgR and HER2.Methods and materialsThis was an institutional review board-approved, retrospective cohort study using our database, prospectively accumulated at three gamma knife institutes, during the 20-year-period since 1998. We excluded patients for whom the day of primary...
Source: Journal of Neuro-Oncology - Category: Cancer & Oncology Source Type: research
ConclusionIn Germany, different specialists are involved in the patients ’ FU care for BC. The detection of long-term problems due to BC treatment is an essential part of FU care.
Source: Archives of Gynecology and Obstetrics - Category: OBGYN Source Type: research
Publication date: Available online 25 January 2020Source: Journal of Pharmaceutical and Biomedical AnalysisAuthor(s): Mirza Muhammad Faran Ashraf Baig, Wing-Fu Lai, Reyaj Mikrani, Mehreen Jabeen, Muhammad Naveed, Muhammad Abbas, Muhammad Asim Farooq, Anam Ahsan, Said Abasse Kassim, Ghulam Jilany Khan, Muhammad Tayyab AnsariAbstractDNA based nano-carriers synthesized from short circular scaffolds (circular DNA nanotechnology) attains stiffer topology for ligand functionalization (neuregulin-1/NRG-1 ligand) and biological applications (targeted drug delivery). Daunorubicin (DR) is a hydrophobic chemical that requires robust ...
Source: Journal of Pharmaceutical and Biomedical Analysis - Category: Drugs & Pharmacology Source Type: research
Publication date: Available online 25 January 2020Source: International Journal of PharmaceuticsAuthor(s): Joan Puig-Rigall, Celia Fernandez-Rubio, Javier González-Benito, Judith E. Houston, Aurel Radulescu, Paul Nguewa, Gustavo González-GaitanoAbstractMiltefosine (MF), an alkylphospholipid originally developed for breast cancer treatment, is a highly active drug for the treatment against leishmaniasis, a neglected tropical disease considered the world’s second leading cause of death by a parasitic agent after malaria. MF exhibits dose-limiting gastrointestinal side effects in patients and its penetrati...
Source: International Journal of Pharmaceutics - Category: Drugs & Pharmacology Source Type: research
More News: Blogging | Breast Cancer | Cancer | Cancer & Oncology | Nurses | Nursing | Women